GGrantIndex
Sort

40,608 grants matching prostate cancer

CANCER AND INFLAMMATION GENETICS

$1,216,954
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Loma Linda University Center for Health Disparities Research

$1,216,382
Marino De Leon · Loma Linda University · P20 · FY2015 · MD

Novel Molecular Therapies of Prostate Cancer

$1,216,100
Dario C. Altieri · Wistar Institute · P01 · FY2012 · CA

1/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership

$1,215,632
Hala Madanat · San Diego State University · U54 · FY2025 · CA

Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods

$1,215,003
Daniel B Vigneron · University Of California, San Francisco · U01 · FY2019 · EB

TARGETING MITOCHONDRIAL INHIBITORS FOR METASTATIC CASTRATE-RESISTANT PROSTATE CANCER

$1,215,000
The Johns Hopkins University · · FY2016 · Department of Defense

DISRUPTING ACCESS TO INTRACELLULAR LIPID DEPOTS TO TREAT ADVANCED PROSTATE CANCER

$1,215,000
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Department of the Army

TARGETING MITOCHONDRIAL INHIBITORS FOR METASTATIC CASTRATE-RESISTANT PROSTATE CANCER

$1,215,000
The Johns Hopkins University · · FY2016 · Department of Defense

IDENTIFICATION OF COLLATERAL LETHAL TARGETS IN PROSTATE CANCER.

$1,214,999
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Department of the Army

IDENTIFYING DIFFERENT METABOLIC SUBTYPES OF PROSTATE CANCER FOR EARLY THERAPEUTIC ASSESSMENT.

$1,214,997
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Defense Health Agency

MOLECULAR CHARACTERIZATION OF INDOLENT PROSTATE CANCER

$1,214,994
The Johns Hopkins University · · FY2012 · Department of Defense

A MULTIPLEX CANCER/TESTIS ANTIGEN-BASED BIOMARKER PANEL TO PREDICT THE AGGRESSIVE PHENOTYPE OF PROSTATE CANCER

$1,214,779
The Johns Hopkins University · · FY2012 · Department of the Army

TRANSCRIPTIONAL MODULATION OF TUMOR-ASSOCIATED MACROPHAGES TO FACILITATE PROSTATE CANCER IMMUNOTHERAPY

$1,214,432
The Johns Hopkins University · · FY2016 · Department of the Army

MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe

$1,214,206
Katherine S Panageas · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA

Transgenic Models for Prostate and Breast Cancer

$1,214,015
Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program

$1,213,253
Khalid Matin · Virginia Commonwealth University · UG1 · FY2019 · CA

3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

$1,212,700
Upender Manne · University Of Alabama At Birmingham · U54 · FY2022 · CA

A Mouse Model for Prostate Cancer

$1,212,233
Cory Abate-Shen · Univ Of Med/Dent Nj-R W Johnson Med Sch · U01 · FY2007 · CA

TRANSLATION OF A NOVEL PET IMAGING COMPANION BIOMARKER TARGETING CD46 FOR TREATMENT PLANNING IN ADENOCARCINOMA AND NEUROENDOCRINE PROSTATE CANCER

$1,211,251
Regents Of The University Of California, San Francisco, The · · FY2020 · Defense Health Agency

EXPLORING CUB DOMAIN-CONTAINING PROTEIN 1 AS A THERANOSTIC TARGET FOR CASTRATION-RESISTANT PROSTATE CANCER.

$1,211,250
Regents Of The University Of California, San Francisco, The · · FY2021 · Defense Health Agency

Environmental Exposure and DNA Damage

$1,209,937
Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

CLINICAL IDENTIFICATION AND TARGETING OF NON-NEUROENDOCRINE LINEAGE PLASTICITY IN CASTRATION-RESISTANT PROSTATE CANCER

$1,209,272
Weill Medical College Of Cornell University · · FY2025 · Defense Health Agency

Novel Molecular Therapies of Prostate Cancer

$1,208,002
Dario C. Altieri · Wistar Institute · P01 · FY2020 · CA

CCR-Frederick Flow Cytometry Core

$1,207,572
Kathleen Noer · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA

Bastyr/UW Oncomycology Translational Research Center

$1,207,565
Leanna J Standish · Bastyr University · U19 · FY2012 · AT